CRYO-CELL International, Inc. (OTCMKTS:CCEL)’s stock price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as low as $7.90. CRYO-CELL International shares last traded at $7.99, with a volume of 600 shares changing hands.
The stock’s fifty day moving average price is $7.90. The firm has a market capitalization of $63.38 million, a price-to-earnings ratio of 31.84 and a beta of -0.19.
CRYO-CELL International (OTCMKTS:CCEL) last posted its quarterly earnings results on Monday, July 15th. The company reported $0.01 EPS for the quarter. The business had revenue of $8.13 million for the quarter. CRYO-CELL International had a negative return on equity of 20.90% and a net margin of 4.57%.
Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases.
See Also: Why do companies pay special dividends?
Receive News & Ratings for CRYO-CELL International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRYO-CELL International and related companies with MarketBeat.com's FREE daily email newsletter.